Increase of electronegative-LDL-fraction ratio and IDL-cholesterol in chronic kidney disease patients with hemodialysis treatment by unknown
Hirowatari et al. Lipids in Health and Disease 2012, 11:111
http://www.lipidworld.com/content/11/1/111SHORT REPORT Open AccessIncrease of electronegative-LDL-fraction ratio and
IDL-cholesterol in chronic kidney disease patients
with hemodialysis treatment
Yuji Hirowatari1*, Yasuhiko Homma2,3, Joe Yoshizawa2,5 and Koichiro Homma2,4,5*Abstract
Background: It is known that the increased level of IDL and oxidized LDL are associated with risk of cardiovascular
disease, and the lipoprotein abnormalities accelerate atherosclerosis. Cardiovascular disease is a major cause of
mortality in chronic kidney disease patients with hemodialysis treatment (HD-Ps). Therefore, the estimation of
lipoprotein profiles is important for prevention of cardiovascular disease in HD-Ps. We previously established an
anion-exchange chromatographic method for measurement of cholesterol level in subclasses of HDL and LDL, IDL,
VLDL, and chylomicron. An electronegative-LDL-fraction contained minimally oxidized-LDL. Lipoprotein profile can
be accurately and conveniently determined by the new method.
Finding: In this study, lipoprotein profiles in HD-Ps and age-matched healthy subjects were estimated by using
our established anion-exchange chromatographic method. The ratio of electronegative-LDL-cholesterol to total
LDL-cholesterol and IDL-cholesterol in HD-Ps were significant higher than those in healthy subjects.
Conclusions: The results suggest that the ratio of electronegative-LDL-cholesterol to total LDL-cholesterol and
IDL-cholesterol obtained by the new method may serve as useful markers for risk of cardiovascular disease in HD-Ps.
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Cardiovascular disease is a major cause of mortality in
chronic kidney disease patients with hemodialysis (HD-
Ps) [1]. It is known that HDL and LDL are decreased,
and IDL and VLDL were increased in end-stage renal
disease [2]. The patients with chronic renal failure fre-
quently have abnormality of lipoprotein metabolism, and
the oxidized modification of LDL and HDL is one of the
major metabolism abnormalities [3]. We previously
reported an anion-exchange chromatographic method
(AEX-HPLC) for measurement of cholesterol level in
two HDL-subclasses, two LDL-subclasses, IDL, VLDL,
and chylomicron, and the cholesterol levels of electro-
negative-LDL-fraction, which is eluted later from the
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distribution, and reproduction in any mediumincreased [4]. The minimally oxidized-LDL (MM-LDL)
prepared by incubating with 2 μmol/L copper ion for
4 hours at 37 °C in vitro [5] was eluted at the position of
electronegative-LDL [4].
In this study, lipoprotein profiles in HD-Ps and age-
matched healthy subjects were estimated by using our
established AEX-HPLC, and those in HD-Ps were com-
pared to those in healthy subjects.
Methods
The study samples were obtained from HD-Ps (n = 25)
and the age-matched healthy controls (n = 25) after
12 hour-overnight fast. The HD-Ps were undergoing
3 times a week, 4 hours hemodialysis treatment using
high-flux polysulphone dialysis membranes and stand-
ard heparin dose for anti-coagulation. This study was
approved by the ethics committee at the Tokai Univer-
sity, and written informed consent was obtained from
all participants.
The used AEX-HPLC was previously reported [4]. The
major components of earlier- and later-eluting fractiontral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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HDL) were HDL3 and HDL2, respectively. The earlier-
eluting subfraction of LDL (nonelectronegative-LDL)
was changed into the later-eluting subfraction of LDL
(electronegative-LDL) after oxidized by incubating
with copper ion in vitro. The values of coefficients of
variation of each lipoprotein cholesterol level were as
follows: within-day assay (nonelectronegative-HDL,
1.45-2.18 %; electronegative-HDL, 0.92-1.80 %; non-
electronegative-LDL, 0.85-2.54 %; electronegative-LDL,
2.08-7.64 %; IDL, 3.83-9.80 %; VLDL, 1.41-11.68 %;
chylomicron, 8.44-19.23 %) and between-day assay (non-
electronegative-HDL, 3.60-3.98 %; electronegative-HDL,
2.69-4.85 %; nonelectronegative-LDL, 2.55-6.67 %; elec-
tronegative-LDL, 5.08-7.62 %; IDL, 6.58-12.10 %; VLDL,
5.69-21.88 %; chylomicron, 20.19-23.50 %) [4].
GFR was estimated using the equation proposed by
the Japanese society of nephrology in 2009: estim-
ated GFR (mL/min/1.73 m2) = 194 x (creatinine)-1.094 x
(age)-0.287 (x 0.739 if female).
The data are presented as the mean+ standard deviation
(SD). Student’s t-test or Mann-Whitney U-test was used
to compare variables between HD-patients and healthy
controls. P values <0.05 were considered significant.
Results
Table 1 shows the data of characteristics and lipoprotein
profiles in HD-Ps and healthy subjects. Age, sex andTable 1 Charactaristics and lipoprotein profiles of hemodialys
Hemodialys
(n =
Age (years) 63 ±
Sex (male/female) 10/
Duration of hemodialysis (years) 1.9 ±
BMI (kg/m2) 21 ±
Total cholesterol (mmol/L) 4.28 ±
Triglyceride (mmol/L) 1.00 ±
LDL cholesterol (mmol/L) 2.22 ±
HDL cholesterol (mmol/L) 1.29 ±
Creatinine(mmol/L) 0.810 ±
Estimated GFR (mL/min/1.73 m2) 4.1 ±
Anion-exchange chromatgraphic method
Nonelectronegative-HDL cholesterol (mmol/L) 0.54 ±
Electronegative-HDL cholesterol (mmol/L) 0.86 ±
Nonelectronegative-LDL cholesterol (mmol/L) 2.29 ±
Electronegative-LDL cholesterol (mmol/L) 0.32 ±
IDL cholesterol (mmol/L) 0.099 ±
VLDL cholesterol (mmol/L) 0.23 ±
Chylomicron cholesterol (mmol/L) 0.075 ±
Electronegative-LDL-s / total LDL (%) 12.5 ±
NS indicates not significant.triglyceride between HD-Ps and healthy subjects
were not significantly different. Total cholesterol, LDL-
cholesterol, HDL-cholesterol and estimated GFR in HD-
Ps were significantly lower than those in healthy
subjects. The cholesterol levels in nonelectronegative-
HDL and nonelectronegative-LDL were lower, and
IDL-cholesterol and the ratio of electronegative-LDL-
cholesterol to total LDL-cholesterol (nonelectronegative-
LDL+ electronegative-LDL) were higher in HD-Ps than
in healthy controls.
Discussion
Shoji et al. reported that the cholesterol levels of HDL
and LDL were lower, and IDL and VLDL were higher in
end-stage renal disease [2]. Furthermore, the IDL-
cholesterol level was the best lipoprotein parameter that
was most closely associated with aortic stiffness in HD-
Ps [2]. We showed the lower cholesterol levels of HDL
and LDL, and the higher IDL-cholesterol level in the
patients with end-stage renal disease on hemodialysis,
and that the VLDL-cholesterol in the patients was
increased, but not significantly (Table 1). Shoji et al. also
propose that the IDL-cholesterol level is a target in the
management of dyslipidemia on renal disease, but the
problem is that it is difficult to measure IDL-cholesterol
levels by ultracentrifugation in routine clinical practice
[2]. Our established AEX-HPLC is a convenient method
to measure IDL-cholesterol levels. In the method, ais patients and healthy controls
is patients Healthy controls P value
25) (n = 25)
13 63 ± 3 NS
15 15/10 NS
1.0
3 22 ± 2 NS
1.02 5.07 ± 0.30 <0.005
0.35 0.86 ± 0.31 NS
0.72 3.00 ± 0.33 <0.0001
0.43 1.68 ± 0.32 <0.001
0.204 0.061 ± 0.010 <0.0001
1.9 69.6 ± 15.3 <0.0001
0.13 0.82 ± 0.11 <0.0001
0.36 0.75 ± 0.26 NS
0.78 2.87 ± 0.30 <0.05
0.13 0.34 ± 0.09 NS
0.040 0.074 ± 0.035 <0.05
0.12 0.20 ± 0.10 NS
0.037 0.077 ± 0.063 NS
3.4 10.4 ± 2.2 <0.05
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column, and lipoprotein classes in serum sample are
separated and eluted by a step-gradient of ion concen-
trations in order. The post-column elute is reacted with
an enzymatic reagent which contains cholesterol esterase
and cholesterol oxidase. The assay time of one sample is
merely 23 minutes. We thought that the AEX-HPLC for
measurement of cholesterol levels of LDL- and HDL-
subclasses, IDL, VLDL, and chylomicron may be inform-
ative for the management of dyslipidemia in HD-Ps.
Miida et al. reported the higher level of preβ1-HDL
and the lower level of HDL3 which is a subfraction of
α-migrating HDL in HD-Ps, and that the conversion
of lecithin: cholesterol acyltransferase of preβ1-HDL to
α-migrating HDL is delayed in HD-Ps [6]. We showed
that nonelectronegative-HDL level of which major com-
ponent is HDL3 was decreased in HD-Ps (Table 1).
Therefore, the cholesterol level of nonelectronegative-
HDL may be informative for the management of dyslipi-
demia in HD-Ps.
Oxidized LDL is generally considered to play an
important role in the development of atherosclerosis.
It was previously reported that the production of oxi-
dized LDL and oxidized HDL were increased in chronic
renal failure [3]. Additionally, it was reported that oxi-
dized LDL/total LDL ratio is higher in HD-Ps with
vascular calcification [7]. We indicated that electronegative-
LDL-cholesterol/total LDL-cholesterol ratio (nonelectro-
negative-LDL+ electronegative-LDL) ratio in HD-Ps was
increased (Table 1).
In conclusion, the present study indicates that elec-
tronegative-LDL/total LDL (nonelectronegative-LDL +
electronegative-LDL) ratio and IDL-cholesterol obtained
by the AEX-HPLC may serve as useful makers for risk
of cardiovascular disease in HD-Ps.
Findings
In this study, the lipoprotein profiles were estimated
with chronic kidney disease patients with hemodialysis
treatment (HD-Ps) by using our developed anion-exchange
chromatographic method. The ratio of electronegative-
LDL-cholesterol to total LDL-cholesterol and IDL-
cholesterol in HD-Ps were significant higher than those
in healthy subjects. The results suggested that the
ratio of electronegative-LDL-cholesterol to total LDL-
cholesterol and IDL-cholesterol obtained by the new
method may serve as useful markers for risk of cardio-
vascular disease in HD-Ps.
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